Literature DB >> 16419170

Effect of a nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on invasion of human colorectal cancer cell line SL-174T.

Li-Bo Yu1, Xin-Shu Dong, Wen-Zhou Sun, Dong-Lu Zhao, Yue Yang.   

Abstract

AIM: To investigate the effect and mechanism of action of the nitric oxide synthase (NOS) inhibitor NG-nitro-L-arginine methyl ester (L-NAME) on invasion and metastasis of human colorectal cancer cell line SL-174T.
METHODS: Human colorectal cancer cell line SL-174T was cultured and treated separately with four different dosages of L-NAME for 72 h. Nitric oxide (NO) production was measured with Griess reagent. The effect of L-NAME on invasion and migration of SL-174T cells were evaluated by using Transwell chambers attached with polycarbonate filters and reconstituted basement membrane (Matrigel). RT-PCR was performed to determine the mRNA levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitor metalloproteinase-2 (TIMP-2).
RESULTS: L-NAME could significantly inhibit NO production of SL-174T in a dose-dependent manner. After being treated for 72 h with 0.2, 0.4, 0.8, and 1.0 mmol/L L-NAME, respectively, the ability of the L-NAME treated SL-174T cells to invade the reconstituted basement membrane decreased significantly (t = 8.056, P< 0.05; t = 14.467, P< 0.01; t = 27.785, P< 0.01; and t = 29.405, P< 0.01, respectively) and the inhibition rates were 10.29%, 19.62%, 34.08%, and 42.23%, respectively. Moreover, L-NAME could inhibit migration of SL-174T cells, and the inhibition rates were 20.76%, 24.95%, 39.43%, and 46.85% for L-NAME at 0.2, 0.4, 0.8, and 1.0 mmol/L, respectively (t= 15.116, P< 0.01). In addition, after treatment with L-NAME, expression of MMP-2 mRNA was significantly decreased (t = 71.238, P< 0.01) and that of TIMP-2 mRNA was markedly increased (t = -13.020, P< 0.01).
CONCLUSION: L-NAME exerts anti-invasive and anti-metastatic effects on SL-174T cell line via downregulating MMP-2 mRNA expression and upregulating TIMP-2 mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16419170      PMCID: PMC4320345          DOI: 10.3748/wjg.v11.i40.6385

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Selective expression of inducible nitric oxide synthase in human prostate carcinoma.

Authors:  T Klotz; W Bloch; C Volberg; U Engelmann; K Addicks
Journal:  Cancer       Date:  1998-05-15       Impact factor: 6.860

2.  Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer.

Authors:  O Gallo; E Masini; L Morbidelli; A Franchi; I Fini-Storchi; W A Vergari; M Ziche
Journal:  J Natl Cancer Inst       Date:  1998-04-15       Impact factor: 13.506

3.  Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue.

Authors:  M Kojima; T Morisaki; Y Tsukahara; A Uchiyama; Y Matsunari; R Mibu; M Tanaka
Journal:  J Surg Oncol       Date:  1999-04       Impact factor: 3.454

4.  Nitric oxide synthase as a marker in colorectal carcinoma.

Authors:  J A Lagares-Garcia; R A Moore; B Collier; M Heggere; F Diaz; F Qian
Journal:  Am Surg       Date:  2001-07       Impact factor: 0.688

Review 5.  Role of nitric oxide in angiogenesis and microcirculation in tumors.

Authors:  D Fukumura; R K Jain
Journal:  Cancer Metastasis Rev       Date:  1998-03       Impact factor: 9.264

6.  Nitric oxide synthase activity in human gynecological cancer.

Authors:  L L Thomsen; F G Lawton; R G Knowles; J E Beesley; V Riveros-Moreno; S Moncada
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

7.  Expression of nitric oxide synthase in human central nervous system tumors.

Authors:  C S Cobbs; J E Brenman; K D Aldape; D S Bredt; M A Israel
Journal:  Cancer Res       Date:  1995-02-15       Impact factor: 12.701

8.  Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

Authors:  M Ziche; L Morbidelli; E Masini; S Amerini; H J Granger; C A Maggi; P Geppetti; F Ledda
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Nitric oxide synthase activity in human lung cancer.

Authors:  H Fujimoto; Y Ando; T Yamashita; H Terazaki; Y Tanaka; J Sasaki; M Matsumoto; M Suga; M Ando
Journal:  Jpn J Cancer Res       Date:  1997-12

10.  Nitric oxide synthase activity in human breast cancer.

Authors:  L L Thomsen; D W Miles; L Happerfield; L G Bobrow; R G Knowles; S Moncada
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  10 in total

1.  Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin deposition.

Authors:  Sarah A Hale; Lindsey Weger; Maurizio Mandala; George Osol
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

2.  Anti-cancer effect of in vivo inhibition of nitric oxide synthase in a rat model of breast cancer.

Authors:  Nikolay Avtandilyan; Hayarpi Javrushyan; Mikayel Ginovyan; Anna Karapetyan; Armen Trchounian
Journal:  Mol Cell Biochem       Date:  2022-08-13       Impact factor: 3.842

Review 3.  Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).

Authors:  Abbas Salihi; Mohammed A Al-Naqshabandi; Zhikal Omar Khudhur; Zjwan Housein; Harmand A Hama; Ramyar M Abdullah; Bashdar Mahmud Hussen; Twana Alkasalias
Journal:  Mol Med Rep       Date:  2022-05-26       Impact factor: 3.423

Review 4.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

5.  Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation.

Authors:  Darren Griffith; Sara Cecco; Ennio Zangrando; Alberto Bergamo; Gianni Sava; Celine J Marmion
Journal:  J Biol Inorg Chem       Date:  2008-05       Impact factor: 3.358

6.  Nitric Oxide (NO) and Cyclooxygenase-2 (COX-2) Cross-Talk in Co-Cultures of Tumor Spheroids with Normal Cells.

Authors:  Roman Paduch; Martyna Kandefer-Szerszeń
Journal:  Cancer Microenviron       Date:  2011-02-22

7.  Effect of storage levels of nitric oxide derivatives in blood components.

Authors:  Melissa A Qazi; Fabiola Rizzatti; Barbora Piknova; Nathawut Sibmooh; David F Stroncek; Alan N Schechter
Journal:  F1000Res       Date:  2012-10-22

8.  Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGFβ.

Authors:  Gang Ren; Xunzhen Zheng; Matthew Bommarito; Samantha Metzger; Yashna Walia; Joshua Letson; Allen Schroering; Andrea Kalinoski; David Weaver; Christopher Figy; Kam Yeung; Saori Furuta
Journal:  Sci Rep       Date:  2019-04-30       Impact factor: 4.379

9.  Loss of Nitric Oxide Induces Fibrogenic Response in Organotypic 3D Co-Culture of Mammary Epithelia and Fibroblasts-An Indicator for Breast Carcinogenesis.

Authors:  Gang Ren; Xunzhen Zheng; Vandana Sharma; Joshua Letson; Andrea L Nestor-Kalinoski; Saori Furuta
Journal:  Cancers (Basel)       Date:  2021-06-05       Impact factor: 6.639

10.  Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy.

Authors:  Manida Suksawat; Anchalee Techasen; Nisana Namwat; Thianrut Boonsong; Attapol Titapun; Piti Ungarreevittaya; Puangrat Yongvanit; Watcharin Loilome
Journal:  FEBS Open Bio       Date:  2018-03-02       Impact factor: 2.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.